Champions Oncology Inc.

10/16/2025 | Press release | Distributed by Public on 10/16/2025 15:06

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.
On October 16, 2025, Champions Oncology, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:
1. Election of Directors.The seven director nominees named in the Company's 2025 proxy statement were elected to serve for a one-year term expiring at the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based upon the following votes:
Director Nominee Votes For Votes Withheld Broker Non-Vote
Ronnie Morris, M.D. 8,992,111 735,954 931,779
Joel Ackerman 8,991,092 736,973 931,779
Robert Brainin 8,894,744 833,321 931,779
David Sidransky, M.D. 8,703,235 1,024,830 931,779
Daniel Mendelson 9,240,584 487,481 931,779
Scott R. Tobin 9,722,734 5,331 931,779
Philip Breitfeld, MD. 9,722,113 5,952 931,779
2. Ratification of Appointment of Independent Registered Accounting Firm.The appointment of EisnerAmper LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2026, was ratified as follows:
Votes For Votes Against Abstain
10,659,115 729 -
3. Non-binding Advisory Resolution Relating to the Compensation of the Company's Named Executive Officers.The proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as described in the Company's 2025 proxy statement, was approved by the following votes:
Votes For Votes Against Abstain Broker Non-Vote
9,720,681 7,262 122 931,779
Champions Oncology Inc. published this content on October 16, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 16, 2025 at 21:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]